ReviewFrontiers in cardiovascular medicine2026
Lysophosphatidylcholine and lysophosphatidic acid as key messengers in atherosclerosis: from a lipid-inflammation vicious cycle to therapeutic translation.
Xue Guan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.